133 related articles for article (PubMed ID: 29254321)
1. Colorectal cancer in patients with type 2 diabetes mellitus: a single-center experience.
Sinagra E; Guarnotta V; Raimondo D; Mocciaro F; Dolcimascolo S; Rizzolo CA; Puccia F; Maltese N; Citarrella R; Messina M; Spada M; Tomasello G; Cappello F; Leone A; Rossi F; Di Mitri R; Morreale GC; Marasà S; Midiri M; Midiri F; Sinagra D
J Biol Regul Homeost Agents; 2017; 31(4):1101-1107. PubMed ID: 29254321
[TBL] [Abstract][Full Text] [Related]
2. Insulin enhances and metformin reduces risk of colorectal carcinoma in type-2 diabetes.
Chen CH; Lin CL; Hsu CY; Kao CH
QJM; 2020 Mar; 113(3):194-200. PubMed ID: 31593243
[TBL] [Abstract][Full Text] [Related]
3. Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012151. PubMed ID: 27749986
[TBL] [Abstract][Full Text] [Related]
4. Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort.
Dehal AN; Newton CC; Jacobs EJ; Patel AV; Gapstur SM; Campbell PT
J Clin Oncol; 2012 Jan; 30(1):53-9. PubMed ID: 22124092
[TBL] [Abstract][Full Text] [Related]
5. Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer.
Garrett CR; Hassabo HM; Bhadkamkar NA; Wen S; Baladandayuthapani V; Kee BK; Eng C; Hassan MM
Br J Cancer; 2012 Apr; 106(8):1374-8. PubMed ID: 22421948
[TBL] [Abstract][Full Text] [Related]
6. Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies.
Thakkar B; Aronis KN; Vamvini MT; Shields K; Mantzoros CS
Metabolism; 2013 Jul; 62(7):922-34. PubMed ID: 23419783
[TBL] [Abstract][Full Text] [Related]
7. Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients.
Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
World J Gastroenterol; 2017 Jul; 23(28):5196-5205. PubMed ID: 28811714
[TBL] [Abstract][Full Text] [Related]
8. Metformin monotherapy for adults with type 2 diabetes mellitus.
Gnesin F; Thuesen ACB; Kähler LKA; Madsbad S; Hemmingsen B
Cochrane Database Syst Rev; 2020 Jun; 6(6):CD012906. PubMed ID: 32501595
[TBL] [Abstract][Full Text] [Related]
9. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis.
Nie Z; Zhu H; Gu M
Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666
[TBL] [Abstract][Full Text] [Related]
10. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
Hemmingsen B; Schroll JB; Lund SS; Wetterslev J; Gluud C; Vaag A; Sonne DP; Lundstrøm LH; Almdal T
Cochrane Database Syst Rev; 2013 Apr; (4):CD009008. PubMed ID: 23633364
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathological characteristics of type 2 diabetes mellitus complicated with colorectal cancer].
Han ZH; Chen JJ; Feng N; Niu PF; Song C; Gao ZY; Gao QK; Ji DB; Wang WB; Lei FM; Gu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Oct; 22(10):966-971. PubMed ID: 31630495
[No Abstract] [Full Text] [Related]
12. The effect of metformin on the survival of colorectal cancer patients with type 2 diabetes mellitus.
Tarhini Z; Manceur K; Magne J; Mathonnet M; Jost J; Christou N
Sci Rep; 2022 Jul; 12(1):12374. PubMed ID: 35859114
[TBL] [Abstract][Full Text] [Related]
13. Effect of metformin on the mortality of colorectal cancer patients with T2DM: meta-analysis of sex differences.
Wang Y; Xiao J; Zhao Y; Du S; Du J
Int J Colorectal Dis; 2020 May; 35(5):827-835. PubMed ID: 32100113
[TBL] [Abstract][Full Text] [Related]
14. Elevated HbA1c is an independent predictor of aggressive clinical behavior in patients with colorectal cancer: a case-control study.
Siddiqui AA; Spechler SJ; Huerta S; Dredar S; Little BB; Cryer B
Dig Dis Sci; 2008 Sep; 53(9):2486-94. PubMed ID: 18409001
[TBL] [Abstract][Full Text] [Related]
15. Suppressive effects of metformin on colorectal adenoma incidence and malignant progression.
Deng M; Lei S; Huang D; Wang H; Xia S; Xu E; Wu Y; Zhang H
Pathol Res Pract; 2020 Feb; 216(2):152775. PubMed ID: 31818523
[TBL] [Abstract][Full Text] [Related]
16. The impact of therapy on the risk of asthma in type 2 diabetes.
Rayner LH; Mcgovern A; Sherlock J; Gatenby P; Correa A; Creagh-Brown B; deLusignan S
Clin Respir J; 2019 May; 13(5):299-305. PubMed ID: 30815978
[TBL] [Abstract][Full Text] [Related]
17. The Risk of TB in Patients With Type 2 Diabetes Initiating Metformin vs Sulfonylurea Treatment.
Pan SW; Yen YF; Kou YR; Chuang PH; Su VY; Feng JY; Chan YJ; Su WJ
Chest; 2018 Jun; 153(6):1347-1357. PubMed ID: 29253553
[TBL] [Abstract][Full Text] [Related]
18. The impact of metformin on survival in diabetes patients with operable colorectal cancer: A nationwide retrospective cohort study.
Chu PT; Chuang TJ; Huang SH; Wu TH; Huang WC; Wang JH
J Int Med Res; 2023 Apr; 51(4):3000605231168033. PubMed ID: 37077173
[TBL] [Abstract][Full Text] [Related]
19. Metformin's role in lowering colorectal cancer risk among individuals with diabetes from the Southern Community Cohort Study.
Lawler T; Walts ZL; Giurini L; Steinwandel M; Lipworth L; Murff HJ; Zheng W; Warren Andersen S
Cancer Epidemiol; 2024 Jun; 90():102566. PubMed ID: 38518387
[TBL] [Abstract][Full Text] [Related]
20. Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer.
Al Omari A; Abdelkhaleq H; Al-Hussaini M; Turfa R; Awad N; Hassan MM; Alfaqih MA; Garrett CR
J Glob Oncol; 2018 Jul; 4():1-10. PubMed ID: 30084749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]